ACHILLION PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07D HETEROCYCLIC COMPOUNDS 42120
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 37218
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 2842
 
  
 
C07B GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 174
 
  
 
C07K PEPTIDES 7129
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0072,762 ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERSNov 20, 17Mar 15, 18[A61K, C07F, C07D, C07B]
2018/0021,360 Combination Therapy Regimen For Treatment Of Selected HCV GenotypesJul 21, 17Jan 25, 18[A61K]
2018/0021,361 COMBINATION DRUG TREATMENT FOR HEPATITIS C INFECTIONJul 21, 17Jan 25, 18[A61K]
2017/0319,572 COMBINATION DRUG TREATMENT FOR HEPATITIS C INFECTIONJul 25, 17Nov 09, 17[A61K]
2017/0298,084 AMIDE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERSJun 29, 17Oct 19, 17[A61K, C07F, C07D, C07B]
2017/0087,174 COMBINATION THERAPY REGIMEN FOR TREATMENT OF HCVSep 29, 16Mar 30, 17[A61K]
2016/0361,329 COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERSAug 24, 16Dec 15, 16[A61K, C07F, C07D, C07B]
2016/0362,399 ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERSAug 24, 16Dec 15, 16[C07D]
2016/0362,433 ETHER COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERSAug 24, 16Dec 15, 16[C07F, C07D]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9833440 Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infectionsFeb 20, 17Dec 05, 17[A61K, C07F, C07D]
9828396 Alkyne compounds for treatment of complement mediated disordersFeb 25, 15Nov 28, 17[A61K, C07F, C07D, C07B]
9796741 Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersFeb 25, 15Oct 24, 17[A61K, C07F, C07D, C07B]
9758537 Compounds for treatment of complement mediated disordersFeb 25, 15Sep 12, 17[A61K, C07F, C07D, C07B]
9732103 Carbamate, ester, and ketone compounds for treatment of complement mediated disordersFeb 25, 15Aug 15, 17[A61K, C07F, C07D, C07B]
9732104 Ether compounds for treatment of complement mediated disordersFeb 25, 15Aug 15, 17[A61K, C07F, C07D, C07B]
9695205 Amide compounds for treatment of complement mediated disordersFeb 25, 15Jul 04, 17[A61K, C07F, C07D, C07B]
9663543 Phosphonate compounds for treatment of complement mediated disordersFeb 25, 15May 30, 17[A61K, C07F, C07D, C07B]
9643986 Factor D inhibitors useful for treating inflammatory disordersFeb 25, 15May 09, 17[A61K, C07F, C07D, C07B]
9610317 4-amino-4-oxobutanoyl peptides as inhibitors of viral replicationDec 04, 15Apr 04, 17[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0226,142 Factor D Inhibitors Useful for Treating Inflammatory DisordersAbandonedApr 24, 17Aug 10, 17[C07F, C07D]
2016/0362,432 PHOSPHONATE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERSAbandonedAug 24, 16Dec 15, 16[C07F]
2016/0016,986 STABILIZED NUCLEOTIDES FOR MEDICAL TREATMENTAbandonedJul 21, 15Jan 21, 16[C07H, A61K]
2014/0309,164 DEUTERATED NUCLEOSIDE PRODRUGS USEFUL FOR TREATING HCVAbandonedApr 14, 14Oct 16, 14[C07H, A61K, C07F]
2014/0271,855 SOVAPREVIR TABLETSAbandonedMar 13, 14Sep 18, 14[A61K]
2014/0206,604 4-AMINO-4-OXOBUTANOYL PEPTIDE CYCLIC ANALOGUES, INHIBITORS OF VIRAL REPLICATIONAbandonedMar 24, 14Jul 24, 14[C07K]
8697641 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replicationWithdrawnDec 10, 09Apr 15, 14[A01N]
2013/0165,471 2-SUBSTITUTED-THIENOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTSAbandonedDec 21, 12Jun 27, 13[C07D]
8445430 Cyclic carboxamide compounds and analogues thereof as of hepatitis C virusExpiredNov 20, 09May 21, 13[A61K, A01N]
8435984 Tertiary amine substituted peptides useful as inhibitors of HCV replicationExpiredFeb 26, 08May 07, 13[A61K, A01N, C07D]
8183263 Heteroaryl substituted thiazolesExpiredMay 22, 08May 22, 12[A61K, A01N, C07D]
2012/0114,601 NEW ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTSAbandonedJan 12, 12May 10, 12[A61K, C07D, A61P]
8173636 Hydroxylthienoquinolones and related compounds as anti-infective agentsExpiredApr 05, 10May 08, 12[A61K, C07D]
2012/0108,576 THIAZOLE COMPOUNDS AND METHODS OF USEAbandonedNov 30, 11May 03, 12[A61K, C07D]
8163693 Urea-containing peptides as inhibitors of viral replicationExpiredSep 24, 08Apr 24, 12[A61K]
8114888 Isothiazoloquinolones and related compounds as anti-infective agentsExpiredFeb 15, 06Feb 14, 12[A61K, C07D]
8106209 Substituted aminothiazole prodrugs of compounds with anti-HCV activityExpiredJun 05, 09Jan 31, 12[A61K, C07D]
8088806 Thiazole compounds and methods of useExpiredMay 09, 06Jan 03, 12[A61K]
2011/0223,132 ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTSAbandonedMar 14, 11Sep 15, 11[A61K, C07D, A61P]
7985541 Quantitative assay for detection of newly synthesized RNA in a cell-free system and identification of RNA synthesis inhibitorsExpiredMar 23, 05Jul 26, 11[C07H, C12Q]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.